GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
(MedPage Today) -- CHICAGO -- Use of GLP-1 receptor agonists in patients with four solid tumor types was significantly associated ...
Tag: GLP1s
Stoking Sexual Arousal and Desire: GLP-1s, Nerve Stimulation, ‘Scream Cream’
(MedPage Today) -- WASHINGTON -- Interest in GLP-1 receptor agonists as a potential aid to sexual desire and arousal disorders ...
GLP-1s and Hepatic Events; ‘Shame, Taboo, Hygiene’; Treating Late-Onset IBD
(MedPage Today) -- Among U.S. adults with diabetes and steatotic liver disease in the All of Us cohort, new use ...
Study on GLP-1s and Breast Cancer ‘Too Good to Be True’?
(MedPage Today) -- Use of GLP-1 receptor agonists in breast cancer patients was linked to lower mortality and recurrence risk ...
More Evidence that GLP-1s May Reduce Risk of Vision-Robbing Eye Diseases
(MedPage Today) -- Patients taking GLP-1 receptor agonists (GLP-1RAs) had a lower likelihood of developing age-related macular degeneration (AMD) compared ...
Teens With T1D, Obesity Reaped Benefits of GLP-1s, Case Studies Suggest
(MedPage Today) -- Two insulin-dependent adolescents with type 1 diabetes and obesity had metabolic improvements after starting a low-dose GLP-1 ...
NPF Primer: GLP-1s Worth Considering as Adjunct for Select Psoriasis Patients
(MedPage Today) -- GLP-1 receptor agonists represent a "biologically plausible and clinically intriguing adjunct" to psoriasis therapy for selected patients, ...
‘Ozempic Personality’: Is Emotional Flattening Another Side Effect of GLP-1s?
(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on ...
Call to Integrate Obesity Management With Surgery, GLP-1s Into Cancer Care
(MedPage Today) -- Integrating the most effective obesity treatments into cancer survivorship offers "an unprecedented opportunity" to improve long-term outcomes ...
Hold GLP-1s Before Endoscopy? Clinical Trial Finds Retained Gastric Contents
(MedPage Today) -- Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume (RGV) if the medication wasn't held ...